Benzinga | Aug 24, 2021 08:22AM EDT

electroCore Announces New Reseller Agreement With Red One Medical Devices, LLC.

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine company, today announced a reseller agreement with Red One Medical Devices, LLC. (Red One). The partnership will further expand availability of electroCore's gammaCore platform in the federal marketplace.

Red One is a Service-Disabled Veteran-Owned Small Business (SDVOSB) offering medical and pharmaceutical goods and services to the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD) hospitals, ensuring compliance with contracting regulations, and providing logistical solutions connected directly into government contracting portals such as ECAT, GSA, DAPA, BPA, and DIBBS.

"As a VA and DoD private sector partner for medical innovation, we are excited to partner with electroCore," said Charles Pollak, President of Red One. "Their gammaCore therapy may help thousands of military personnel, family and veterans suffering from primary headache. Painful and disabling headaches torment more than 20% of former service members, especially those from the post-9/11 combat veteran cohort. We look forward to partnering with electroCore to make the therapy more easily accessible in the federal marketplace."

"Partnering with Red One will help accelerate adoption of electroCore's therapy within the government channel," commented Dan Goldberger, Chief Executive Officer of electroCore. "Our partnership gives electroCore access to a variety of contracting portals enabling easier procurement of gammaCore therapy across veteran and active military channels. We have just begun to scratch the surface of the help we can provide to our veterans, troops, and family members in VA and DoD, and we are honored to partner with an SDVOSB to make gammaCore more widely available to those veterans and active-duty military who can benefit from our therapy."